Prevalence and Correlates of Major Depressive Symptoms among Black Men with Prostate Cancer

Kinlock, Ballington L.; Parker, Lauren; Howard, Daniel; Bowie, Janice V.; LaVeist, Thomas A.; Thorpe, Roland J.

doi:10.18865/ed.27.4.429

Cited by 14 publications

(11 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…70 Treatment decisional regret affects 4% to 18% of prostate cancer survivors in the near term, 48,71,72 and emerging evidence suggests that its association with depression is due to repetitive negative thinking. 70 Treatment decisional regret affects 4% to 18% of prostate cancer survivors in the near term, 48,71,72 and emerging evidence suggests that its association with depression is due to repetitive negative thinking.…”

Section: Study Implicationsmentioning

confidence: 99%

“…Lastly, to the best of our knowledge, this study is the first to demonstrate an association between treatment decisional regret and depression. 70 Treatment decisional regret affects 4% to 18% of prostate cancer survivors in the near term, 48,71,72 and emerging evidence suggests that its association with depression is due to repetitive negative thinking. 73,74 Available evidence also suggests that treatment decisional regret is likely to occur in prostate cancer survivors who assume a passive role in cancer treatment decision making.…”

Section: Study Implicationsmentioning

confidence: 99%

See 1 more Smart Citation

Prevalence and predictors of probable depression in prostate cancer survivors

Erim

Bensen

Mohler

et al. 2019

Cancer

View full text Add to dashboard Cite

Background The early diagnosis and treatment of depression are cancer care priorities. These priorities are critical for prostate cancer survivors because men rarely seek mental health care. However, little is known about the epidemiology of depression in this patient population. The goal of this study was to describe the prevalence and predictors of probable depression in prostate cancer survivors. Methods The data were from a population‐based cohort of North Carolinian prostate cancer survivors who were enrolled from 2004 to 2007 in the North Carolina–Louisiana Prostate Cancer Project (n = 1031) and were prospectively followed annually from 2008 to 2011 in the Health Care Access and Prostate Cancer Treatment in North Carolina study (n = 805). Generalized estimating equations were used to evaluate an indicator of probable depression (Short Form 12 mental composite score ≤48.9; measured at enrollment and during the annual follow‐up) as a function of individual‐level characteristics within the longitudinal data set. Results The prevalence of probable depression fell from 38% in the year of the cancer diagnosis to 20% 6 to 7 years later. Risk factors for probable depression throughout the study were African American race, unemployment, low annual income, younger age, recency of cancer diagnosis, past depression, comorbidities, treatment decisional regret, and nonadherence to exercise recommendations. Conclusions Depression is a major challenge for prostate cancer survivors, particularly in the first 5 years after the cancer diagnosis. To the authors' knowledge, this is the first study to demonstrate an association between treatment decisional regret and probable depression.

show abstract

Section: Study Implicationsmentioning

confidence: 99%

Section: Study Implicationsmentioning

confidence: 99%

Prevalence and predictors of probable depression in prostate cancer survivors

Erim

Bensen

Mohler

et al. 2019

Cancer

View full text Add to dashboard Cite

show abstract

“…The prevalence of depressive symptoms in PCa patients was 65.9% in our study. We compared our results with other empirical studies of depression in PCa patients using the same cut-off: The prevalence of depressive symptoms among Kinlock's sample of Black men was approximately 33% [36]. The prevalence of depressive symptoms in our study was very high, and there might be two reasons for this situation.…”

Section: Discussionmentioning

confidence: 54%

Effects of social support, hope and resilience on depressive symptoms among patients with newly diagnosed prostate cancer

Zhao

Sun

Yang³

2020

Preprint

View full text Add to dashboard Cite

Background The prevalence of depression symptoms and related modifiable factors in prostate cancer (PCa) are not well evaluated. We aimed to assess the effects of perceived social support, hope and resilience on depressive symptoms in newly diagnosed PCa patients, and to evaluate the role of hope and resilience as mediators of that relationship. Method A cross-sectional study was analyzed in consecutive inpatients with PCa during the months of January 2018 and August 2019. A questionnaire was administered to 667 patients. All registered patients were all volunteers and anonymous. Depressive symptoms, perceived social support, hope and resilience were measured anonymously. Out of 667 patients, a total of 564 effective respondents became our subjects. Hierarchical linear regression was used to identify the factors associated with depressive symptoms. Asymptotic and resampling strategies were used to conduct the mediating effects of hope and resilience Results The prevalence of depressive symptoms was 65.9% in PCa patients . Hierarchical regression analyses indicated that perceived social support, hope, and resilience together accounted for 27.5% variance of depressive symptoms. Support from family, hope, and resilience significantly associated with depressive symptoms, respectively. Hope (a*b = -0.0783, BCa95% CI:–0.134 to–0.0319, p < 0.05), and resilience (a*b = -0.1315, BCa95% CI:–0.1894 to–0.0783, p < 0.05) significantly mediated the association between perceived social support and depressive symptoms. Conclusions The high prevalence of depressive symptoms among newly diagnosed PCa patients should receive more attention. Perceived social support, hope and resilience could be positive resources for combating depressive symptoms, and hope and resilience mediated the association between perceived social support and depressive symptoms. Enhancing social support, particularly the support form family, and improving patients’ outlook and resilience may be potential targets for future psychosocial interventions aimed at reducing depressive symptoms.

show abstract

“…The prevalence of depressive symptoms in PCa patients was 65.9% in our study. We compared our results with other empirical studies of depression in PCa patients using the same cut-off: (1) Hoyt and Carpenter reported the prevalence of depressive symptoms (23%, N=15) in patients with radical prostatectomy or radiation therapy [39]; (2) Lin et al found that 75 Taiwan patients (56.4%) had depression scores greater than or equal to 16 on the CES-D [40]; (3) The prevalence of depressive symptoms among Kinlock's sample of Black men was approximately 33% [41]. Cancer as a stressor can interrupt patients' emotional, social, and career development, setting the stage for challenges to adjustment during distinct phases in the life course.…”

Section: Discussionmentioning

confidence: 99%

Effects of social support, hope and resilience on depressive symptoms within 18 months after diagnosis of prostate cancer

Zhao

Sun

Yang

2020

Preprint

View full text Add to dashboard Cite

Background: The prevalence of depression symptoms and related modifiable factors in prostate cancer (PCa) are not well evaluated. We aimed to assess the effects of perceived social support, hope and resilience on depressive symptoms within 18 months after diagnosis of PCa, and to evaluate the role of hope and resilience as mediators of that relationship.Method: A cross-sectional study was analyzed in consecutive inpatients with PCa during the months of January 2018 and August 2019. A questionnaire was administered to 667 patients. All registered patients were all volunteers and anonymous. Depressive symptoms, perceived social support, hope and resilience were measured anonymously. Out of 667 patients, a total of 564 effective respondents (< 30% missing data) became our subjects. Hierarchical linear regression was used to identify the factors associated with depressive symptoms. Asymptotic and resampling strategies were used to conduct the mediating effects of hope and resilienceResults: The prevalence of depressive symptoms was 65.9% in PCa patients. Hierarchical regression analyses indicated that perceived social support, hope, and resilience together accounted for 27.5% variance of depressive symptoms. Support from family, hope, and resilience significantly associated with depressive symptoms, respectively. Hope (a*b = -0.0783, BCa95% CI:-0.134 to -0.0319, p < 0.05), and resilience (a*b = -0.1315, BCa95% CI:-0.1894 to -0.0783, p < 0.05) significantly mediated the association between perceived social support and depressive symptoms.Conclusions: The high prevalence of depressive symptoms among PCa patients should receive more attention. Perceived social support, hope and resilience could be positive resources for combating depressive symptoms, and hope and resilience mediated the association between perceived social support and depressive symptoms. Enhancing social support, particularly the support form family, and improving patients’ outlook and resilience may be potential targets for future psychosocial interventions aimed at reducing depressive symptoms.

show abstract

Prevalence and Correlates of Major Depressive Symptoms among Black Men with Prostate Cancer

Cited by 14 publications

References 37 publications

Prevalence and predictors of probable depression in prostate cancer survivors

Prevalence and predictors of probable depression in prostate cancer survivors

Effects of social support, hope and resilience on depressive symptoms among patients with newly diagnosed prostate cancer

Effects of social support, hope and resilience on depressive symptoms within 18 months after diagnosis of prostate cancer

Contact Info

Product

Resources

About